Skip to main content
. Author manuscript; available in PMC: 2012 Jul 25.
Published in final edited form as: Clin Pharmacol Ther. 2011 Dec 28;91(2):234–242. doi: 10.1038/clpt.2011.216

Table 3.

Pharmacokinetic parameter estimates of epoetin alpha (standard errors) from the parallel group trial

Vc (L) Vp (L) CLlin (L/h) Q (L/h) Vmax (IU/h) Km (IU/L) C0 (IU/L) corr CLlin Vc
μR 4.05 (0.14) 2.58 (0.46) 0.36 (0.06) 0.34 (0.06) 341.22 (38.09) 90.83 (17.74) 8.26 (0.34)
βT 0.06 (0.05) 0.17 (0.23) 0.17 (0.23) 0.20 (0.21) −0.07 (0.16) −0.16 (0.28) 0.06 (0.06)
BSV 0.21 (0.01) 0.16 (0.04) 0.34 (0.02) 0.13 (0.05) 0.13 (0.03) 0.39 (0.05) 0.25 (0.02) 0.9 (/)

b 0.15 (0.003)

b, proportional error model parameter; BSV, standard deviation for the between-subject variability; βT, formulation effect for the test formulation; corrCLlinVc, correlation between CLlin and Vc; μR, fixed effects for the formulation of reference